SANOFI DUPIXENT
-
EU approves Sanofi's Dupixent for 'smoker's lungs'
The EU Commission approved Dupixent to treat chronic obstructive pulmonary disease (COPD) in patients that cannot be helped by standard inhaled drugs, Sanofi said in a statement, following a recommendation by the European Medicines Agency (EMA) at the end of May.
Advertisement
Advertisement